1,2-Bis[(2R,5R)-2,5-(dimethylphospholano]ethane(cyclooctadiene)rhodium(I) tetrafluoroborate

• Catalog No.: 675555
• CAS Number: 305818-67-1
• M. F.: C22H40BF4P2Rh
• M. W.: 556.2106348

SYNONYMS

• Title: 1,2-双[(2R,5R)-2,5-(二甲基磷]乙烷(环辛二烯)四氟硼酸铑(I)
• IUPAC name: λ^1-rhodium(1+) ion (2R,5R)-1-{2-[(2R,5R)-2,5-dimethylphospholan-1-yl]ethyl}-2,5-dimethylphospholane cycloocta-1,5-diene tetrafluoroboranuide
• IUPAC Traditional name: λ^1-rhodium(1+) ion (2R,5R)-1-{2-[(2R,5R)-2,5-dimethylphospholan-1-yl]ethyl}-2,5-dimethylphospholane 1,5-cyclooctadiene tetrafluoroborate

DATABASE IDS

• PubChem SID: 24885288
• CAS Number: 305818-67-1

PROPERTIES

• Empirical Formula (Hill Notation): C22H40BF4P2Rh
• GHS Signal Word: Warning
• GHS Hazard statements: H315-H319-H335
• European Hazard Symbols: Irritant (Xi)
• Personal Protective Equipment: dust mask type N95 (US), Eyeshields, Gloves
• GHS Precautionary statements: P261-P305 + P351 + P338
• Risk Statements: 36/37/38
• Safety Statements: 26
• German water hazard class: 3

DETAILS

Description (English)

Packaging
100, 500 mg in glass bottle
Legal Information
Sold in collaboration with Kanata Chemical Technologies, Inc. for research purposes only. These compounds were made and sold under license from E.I. du Pont de Nemours and Company, which license does not include the right to use the compounds in producing products for sale in the pharmaceutical field.
Application
DuPhos and BPE Ligands: Highly Efficient Privileged LigandsCatalyst for:
• Preparation of substituted phenylalanine via asymmetric hydrogenation of N-acetyldehydroamino acid precursor1
• Enantioselective preparation of trifluoromethyl amino acids via asymmetric hydrogenation2
• Asymmetric hydrogenation of acetamidocinnamate3

Description (简体中文)

包装
100, 500 mg in glass bottle
Legal Information
与 Kanata Chemical Technologies, Inc. 联合销售，仅供研究使用。这些化合物由 E.I. du Pont de Nemours and Company 授权制造和销售，此许可不包括利用这些化合物制备在制药领域销售的产品的权利。
Application
DuPhos and BPE Ligands: Highly Efficient Privileged LigandsCatalyst for:
• Preparation of substituted phenylalanine via asymmetric hydrogenation of N-acetyldehydroamino acid precursor1
• Enantioselective preparation of trifluoromethyl amino acids via asymmetric hydrogenation2
• Asymmetric hydrogenation of acetamidocinnamate3